Stay updated on Tagraxofusp in Secondary AML Clinical Trial

Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision was updated from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:43:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:28:14.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    UI label capitalization was updated from 'Find Contact Information' to 'Find contact information'. A new 'Revision: v3.7.0' badge appears, replacing the previous version indicator.
    Difference
    0.2%
    Check dated 2026-09-21T20:36:37.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The study record history now lists the latest revision as v3.6.6, replacing the previous version v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-31T16:56:31.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry v3.6.5. The previous revision v3.6.4 has been removed.
    Difference
    0.1%
    Check dated 2026-08-10T10:30:08.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 entry was added and the previous Revision: v3.6.3 entry was removed in the study record history, indicating a small backend/UI update reflected in the log.
    Difference
    0.1%
    Check dated 2026-07-27T06:27:37.000Z thumbnail image

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.